Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative ColitisGeorge D. Ferry, Bobbette A. Jones, Barbara S. Kirschner et al.|Journal of Pediatric Gastroenterology and Nutrition|1993Cited by 66
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal VulnerabilityDanièl Thomas, Ravindra Majeti|Cancer Discovery|2022Cited by 59
Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative ColitisGeorge D. Ferry, Bobbette A. Jones, Barbara S. Kirschner et al.|Journal of Pediatric Gastroenterology and Nutrition|1993Cited by 13
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohortMithun Vinod Shah, Devendra Hiwase, Antoine N. Saliba et al.|Blood Cancer Journal|2025Cited by 6
Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative NeoplasmsChloe Thompson-Peach, Danièl Thomas|BIO-PROTOCOL|2023Cited by 1